Top Biomarkers Measured In A Longevity Test And What They Reveal About Your Healthspan

Most people don’t want to live to 100. They want to live to 80 without being on six different medications, unable to climb their own stairs.
That gap between living long and living well is the whole point of a longevity test. Your annual GP check-up isn’t built for it. It’s built to catch things that have already started breaking. The labs you run through a clinic in Orchard Road or a polyclinic in Mumbai will flag a problem once it shows up. They won’t tell you the problem is brewing eight years out.
A proper longevity panel will. Here’s what it actually looks at, and why each number is worth knowing before you need it.
Inflammation: The Slow Drip Behind Almost Everything
If you’ve ever wondered why heart disease, dementia, and type 2 diabetes all seem to share the same risk factors, the answer is mostly inflammation. Not the kind you feel after a bad ankle sprain. The quieter, lower-grade version that runs in the background for years.
Standard CRP testing misses it. The number comes back “normal” because the test wasn’t sensitive enough to begin with.
A longevity test runs hs-CRP instead, which picks up inflammation at concentrations the regular test can’t see. Worth pairing it with homocysteine, which has links to both cognitive decline and arterial damage, and IL-6 if your clinic offers it. IL-6 is what researchers tend to point to when they talk about “inflammaging”, that slow inflammatory creep tied to age-related decline.
A surprising number of people walk into a first appointment feeling completely fine and find their hs-CRP sitting at 2 mg/L. Not catastrophic. But not where you want it either.
Metabolic Health: Where The Real Damage Hides
Of every system you can test, this is the one with the longest lag between things going wrong and anything actually showing up. Fasting glucose is famously bad at catching early dysfunction. By the time it climbs into prediabetic territory, your insulin has often been doing overtime for the better part of a decade to keep things looking normal.
So a longevity test won’t just look at glucose. It looks at glucose alongside:
- HbA1c, your rolling three-month average
- Fasting insulin, almost never ordered in standard panels
- HOMA-IR, an insulin resistance score calculated from the two above
- Triglyceride-to-HDL ratio, a quick proxy for metabolic syndrome
HOMA-IR is the one that catches people off guard. It tells you how hard your pancreas is working to keep your blood sugar looking presentable. Anything above 1.5 suggests you’ve already started down the insulin resistance road, often years before HbA1c shifts even a single decimal.
This is also the most fixable area on the list. Sleep, food, lifting heavy things twice a week. Twelve weeks of that and these numbers move.
Cardiovascular Markers: Your Standard Lipid Panel Is Outdated
The cholesterol panel your GP runs hasn’t really changed since the 1990s. The science around what predicts a heart attack absolutely has.
Here’s the difference in plain terms:
| Marker | Standard Panel | Modern Longevity Test |
| LDL-C | Measures cholesterol carried | Often replaced by ApoB |
| ApoB | Not measured | Counts the actual harmful particles |
| Lp(a) | Not measured | Tested once, genetic risk for life |
| Particle size | Not measured | Picked up via NMR |
| Oxidised LDL | Not measured | Shows real arterial damage risk |
ApoB has become the single best blood test for predicting cardiovascular risk, ahead of LDL-C, and yet it’s still not standard in most general check-ups. Lp(a) is the other one nobody talks about. It’s mostly genetic, you only need to test it once, and roughly one in five people carry elevated levels without ever finding out until something goes wrong.
If you’re going to push your doctor for one upgrade, push for these two.
Hormones, Vitamins, And The Layer Almost Nobody Checks
This is the section where most first-time longevity panels throw up at least one surprise.
Take vitamin D. Despite living near the equator, vitamin D deficiency is everywhere in Singapore and across urban India. Office hours, indoor air-conditioned everything, sunscreen, pollution. A longevity test will run 25-hydroxyvitamin D, and the optimal target sits closer to 40 to 60 ng/mL, not the “you’re not deficient” floor of 30 that most labs use.
The rest of the layer is worth annual tracking too. Vitamin B12 and folate for energy and cognition. Ferritin and serum iron, because low ferritin is one of the most under-diagnosed reasons for being tired all the time, particularly in women. Free testosterone and DHEA-S for muscle, libido, and metabolic resilience. A full thyroid panel that includes free T3 and free T4, not just TSH on its own, since TSH alone can completely miss subclinical thyroid problems. And the omega-3 index, which tells you the actual percentage of EPA and DHA in your red blood cell membranes.
A comprehensive longevity test pulls all of these together rather than scattering them across three separate clinic visits and four different forms.
Biological Age: The Newest Layer And The Most Interesting One
Standard biomarkers tell you how a specific system is doing. Biological age markers try to tell you how the whole machine is ageing as a unit.
The most credible of these right now is DNA methylation-based epigenetic age. The most cited versions are PhenoAge and GrimAge. They read patterns at thousands of sites across your DNA and spit out an estimate of how old your body is functioning, regardless of what the calendar says.
Telomere length is the older marker. Still useful, with caveats. GlycanAge is newer and tends to respond more quickly to lifestyle change, which makes it the more practically interesting of the three if you’re actually trying to track interventions.
None of these are perfect. What they give you is a baseline. Test once. Change something real, sleep, training volume, drinking, supplementation. Test again twelve to eighteen months later. The change between the two readings is where the actual signal lives.
Conclusion
A single longevity test isn’t worth that much on its own. It’s a snapshot. Two of them, a year apart, is a trend. Three is something you can actually plan around.
None of the markers above are exotic. They’re available across decent labs in Mumbai, Bengaluru, Singapore, and most major cities. The thing that changes the outcome isn’t access. It’s whether someone reads them through a healthspan lens or a disease-screening one. That shift in interpretation is what makes the whole exercise worth doing.




